Outpatient

Cerebral Inc. to Stop Prescribing Most Controlled Substances by Fall Amid Telehealth Controlled Substance Prescribing Changes

Cerebral Inc., a fast-growing mental health and medication management startup based in San Francisco, recently announced it will stop prescribing most controlled substances to new patients starting this Friday....

Talkspace Partners with Evernow to Elevate Menopause Mental Health Support for Women

In recent years, the importance of mental health has gained significant attention, and now more companies are recognizing...

Telehealth Usage Surges in Behavioral Health, Especially Among Commercially-Insured Patients

The adoption of telehealth for behavioral health services has accelerated dramatically over the past few years, with commercially-insured...

The Growing Rural Opioid Crisis: Challenges and Opportunities for Treatment

Opioid addiction has become a significant issue in the United States, with the rural opioid crisis hitting communities...

Concert Health Secures $42 Million Series B to Expand Collaborative Behavioral Health Care

Concert Health, a technology-driven behavioral health medical group, recently closed a $42 million Series B funding round. The...
spot_img

Blended Health: Bridging the Gap Between Outpatient and In-Facility Mental Health Care

In today’s evolving mental health landscape, partial hospitalization programs (PHPs) are becoming a vital part of the continuum of care. Blended Health, a new...

Behavioral Health M&A 2024: Platform Deals Poised for a Comeback After a Year of Reckoning

After a turbulent year marked by economic uncertainty, slowed growth, and a cautious investment climate, the behavioral health sector is showing signs of recovery...

Breaking Down the SAMHSA Opioid Treatment Rule 2024: What It Means for Patients and Providers

In a pivotal move aimed at modernizing addiction care and expanding access to opioid use disorder (OUD) treatment, the Substance Abuse and Mental Health...

Guidelight: Revolutionizing Behavioral Health Care with GV and Triple Aim’s Backing

In a pivotal moment for the behavioral health industry, GV (formerly Google Ventures) and Triple Aim have teamed up to invest in Guidelight, a...

Addressing the Growing Youth Mental Health Crisis: Insights from Embark Behavioral Health CEO Alex Stavros

The youth mental health crisis in the United States has become an urgent and complex issue. According to the CDC, over 40% of high...

The Future of Substance Use Disorder Treatment: Why Affordable Programs Are Leading the Market

The substance use disorder (SUD) treatment landscape is undergoing a significant transformation. Contrary to popular belief, the largest patient population and the majority of...
spot_img